BR112014017788A2 - interferon fusion protein and immunoglobulin fc section - Google Patents

interferon fusion protein and immunoglobulin fc section

Info

Publication number
BR112014017788A2
BR112014017788A2 BR112014017788A BR112014017788A BR112014017788A2 BR 112014017788 A2 BR112014017788 A2 BR 112014017788A2 BR 112014017788 A BR112014017788 A BR 112014017788A BR 112014017788 A BR112014017788 A BR 112014017788A BR 112014017788 A2 BR112014017788 A2 BR 112014017788A2
Authority
BR
Brazil
Prior art keywords
immunoglobulin
section
fusion protein
interferon fusion
interferon
Prior art date
Application number
BR112014017788A
Other languages
Portuguese (pt)
Inventor
Chin Wu Chung
Ting Chen Han
Yung Kuo Tsun
Original Assignee
Sbc Virbac Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sbc Virbac Biotech Co Ltd filed Critical Sbc Virbac Biotech Co Ltd
Publication of BR112014017788A2 publication Critical patent/BR112014017788A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Abstract

ÿþrÿþr

BR112014017788A 2012-01-19 2013-01-18 interferon fusion protein and immunoglobulin fc section BR112014017788A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201210016618 2012-01-19
PCT/CN2013/070693 WO2013107388A1 (en) 2012-01-19 2013-01-18 Interferon and immune globulin fc section fusion protein

Publications (1)

Publication Number Publication Date
BR112014017788A2 true BR112014017788A2 (en) 2017-06-27

Family

ID=48798651

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014017788A BR112014017788A2 (en) 2012-01-19 2013-01-18 interferon fusion protein and immunoglobulin fc section

Country Status (5)

Country Link
KR (1) KR20150002588A (en)
CN (2) CN103214579B (en)
BR (1) BR112014017788A2 (en)
PH (1) PH12014501643A1 (en)
WO (1) WO2013107388A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104292337A (en) * 2013-07-17 2015-01-21 施怀哲维克生物科技股份有限公司 Porcine fusion interferon
CN110055272A (en) * 2019-04-18 2019-07-26 西北农林科技大学 A kind of targeting antibodies therapeutic agent inhibiting PRRS virus multiplication
CN113717270A (en) * 2020-05-26 2021-11-30 成都彤琦恩生物科技有限公司 Porcine interferon-alpha 8 mutant and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
CN101967196A (en) * 2010-11-10 2011-02-09 夏志南 Interferon fusion protein, preparation thereof and application thereof

Also Published As

Publication number Publication date
CN103214579A (en) 2013-07-24
PH12014501643A1 (en) 2014-10-13
CN103214579B (en) 2015-08-26
WO2013107388A1 (en) 2013-07-25
CN105001340A (en) 2015-10-28
KR20150002588A (en) 2015-01-07

Similar Documents

Publication Publication Date Title
MA46534A (en) FC HETERODIMERIC FUSION PROTEIN IL15 / IL15R
HK1208827A1 (en) Interleukin-2 fusion proteins and uses thereof -2
HK1208476A1 (en) Anti-b7-h6 antibody, fusion proteins, and methods of using the same b7-h6
UY34017A (en) FUSION PROTEINS AND COMBINATION VACCINES
EP3019531A4 (en) Immunoglobulin fusion proteins and compositions thereof
CL2014003605A1 (en) Interleukin-10 fusion proteins and uses thereof
EA201590993A1 (en) HETERODIMERNY IMMUNOHLOBULINS
BR112015003838A2 (en) antibody and protein formulations
DK2940135T3 (en) Heterodimerized polypeptide
EP2950814A4 (en) Pd-l1 and pd-l2-based fusion proteins and uses thereof
CO7020851A2 (en) Proteins and modified peptides
BR112014019825A2 (en) CHEMIOENZYMATIC GLYCOENGINEERING OF ANTIBODIES AND FC FRAGMENTS OF THE SAME
DK3381943T3 (en) ANTI-KIT ANTIBODIES AND USES THEREOF
EP2723380A4 (en) Light chain immunoglobulin fusion proteins and methods of use thereof
EP2975052A4 (en) Epitope of rsv fusion protein and antibody identifying same
CL2016000219A1 (en) Therapeutic fusion proteins.
EP3049445A4 (en) Interleukin-2 fusion proteins and uses thereof
SMT201500203B (en) Anti-cancer fusion protein
EP3000825A4 (en) Trans-tumoral peptide specific to neuropilin and fusion protein having same peptide fused therein
HRP20190434T1 (en) Fusion protein
DK3434760T3 (en) METHODS OF INCREASING THE MANNOSE CONTENT OF RECOMBINANT PROTEINS
DK3173102T3 (en) FGFR-FC fusion protein and its use
BR112015009462A2 (en) stable pharmaceutical composition of tnfr: fc fusion protein
EP2969009A4 (en) Modified fc fusion proteins
EP2930189A4 (en) Chemokine-cytokine fusion protein and application thereof

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11N Dismissal: publication cancelled
B07D Technical examination (opinion) related to article 229 of industrial property law

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B15K Others concerning applications: alteration of classification

Ipc: C07K 19/00 (2006.01), C12N 15/62 (2006.01), C12N 1

B07E Notice of approval relating to section 229 industrial property law
B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements